EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 225 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2016. The put-call ratio across all filers is 4.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,469,000 | +5.4% | 136,093 | +1.2% | 0.24% | +3.9% |
| Q3 2016 | $4,241,000 | +40.2% | 134,506 | +25.0% | 0.23% | +46.2% |
| Q2 2016 | $3,025,000 | -35.8% | 107,577 | -17.0% | 0.16% | -48.5% |
| Q1 2016 | $4,714,000 | +0.8% | 129,672 | +10.9% | 0.31% | +42.1% |
| Q4 2015 | $4,677,000 | +41.0% | 116,908 | +0.5% | 0.22% | -1.8% |
| Q3 2015 | $3,316,000 | -6.9% | 116,380 | +7.6% | 0.22% | -5.2% |
| Q2 2015 | $3,563,000 | -8.0% | 108,145 | -19.7% | 0.23% | -0.4% |
| Q1 2015 | $3,872,000 | -14.3% | 134,642 | -18.8% | 0.23% | -15.3% |
| Q4 2014 | $4,518,000 | +19.0% | 165,913 | -6.9% | 0.28% | +18.5% |
| Q3 2014 | $3,798,000 | -3.6% | 178,204 | +1.6% | 0.23% | -6.8% |
| Q2 2014 | $3,941,000 | +17.0% | 175,452 | +31.7% | 0.25% | +7.3% |
| Q1 2014 | $3,367,000 | +8.9% | 133,253 | -1.0% | 0.23% | +8.4% |
| Q4 2013 | $3,093,000 | +74.6% | 134,541 | +44.7% | 0.21% | +68.5% |
| Q3 2013 | $1,771,000 | – | 92,963 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIMZ Investment Advisors, LLC | 52,590 | $621 | 0.29% |
| Values First Advisors, Inc. | 33,942 | $400,858 | 0.28% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 91,000 | $1,075,000 | 0.23% |
| SummerHaven Investment Management, LLC | 25,347 | $299,348 | 0.18% |
| PALISADE CAPITAL MANAGEMENT, LP | 501,672 | $5,924,746 | 0.16% |
| CORNERCAP INVESTMENT COUNSEL INC | 67,457 | $796,667 | 0.14% |
| Edgestream Partners, L.P. | 94,553 | $1,116,671 | 0.13% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 86,569 | $1,022,380 | 0.12% |
| DUALITY ADVISERS, LP | 77,298 | $912,889 | 0.10% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,253,042 | $14,798,427 | 0.10% |